- Home
- TRST vs SVRA Comparison
TRST vs SVRA Comparison
Compare TRST & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- SVRA
- Stock Information
- Founded
- TRST 1902
- SVRA 2007
- Country
- TRST United States
- SVRA United States
- Employees
- TRST N/A
- SVRA N/A
- Industry
- TRST Major Banks
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- SVRA Health Care
- Exchange
- TRST Nasdaq
- SVRA Nasdaq
- Market Cap
- TRST 540.7M
- SVRA 528.3M
- IPO Year
- TRST N/A
- SVRA N/A
- Fundamental
- Price
- TRST $35.58
- SVRA $2.21
- Analyst Decision
- TRST
- SVRA Buy
- Analyst Count
- TRST 0
- SVRA 5
- Target Price
- TRST N/A
- SVRA $5.60
- AVG Volume (30 Days)
- TRST 106.8K
- SVRA 1.2M
- Earning Date
- TRST 07-21-2025
- SVRA 08-11-2025
- Dividend Yield
- TRST 4.05%
- SVRA N/A
- EPS Growth
- TRST N/A
- SVRA N/A
- EPS
- TRST 2.68
- SVRA N/A
- Revenue
- TRST $173,999,000.00
- SVRA N/A
- Revenue This Year
- TRST $13.13
- SVRA N/A
- Revenue Next Year
- TRST N/A
- SVRA N/A
- P/E Ratio
- TRST $13.28
- SVRA N/A
- Revenue Growth
- TRST N/A
- SVRA N/A
- 52 Week Low
- TRST $27.18
- SVRA $1.89
- 52 Week High
- TRST $38.89
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- TRST 78.71
- SVRA 41.30
- Support Level
- TRST $33.29
- SVRA $1.98
- Resistance Level
- TRST $33.73
- SVRA $2.29
- Average True Range (ATR)
- TRST 0.75
- SVRA 0.14
- MACD
- TRST 0.40
- SVRA 0.02
- Stochastic Oscillator
- TRST 99.90
- SVRA 42.19
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.